PharMerica sells to investment firm
By HME News Staff
Updated Fri December 8, 2017
LOUISVILLE, Ky. - PharMerica, a specialty pharmacy services provider, has been acquired by global investment firm KKR and Walgreens Boots Alliance, it announced Dec. 7. PharMerica shareholders will receive an amount in cash equal to $29.25 per share of PharMerica common stock, without interest, and its stock will cease trading on the NYSE, according to a press release. PharMerica operates 96 institutional pharmacies, 20 specialty home infusion pharmacies and 5 specialty oncology pharmacies in 45 states. In March, PharMerica acquired New Hyde Park, N.Y.-based CareMed Specialty Pharmacy.
Comments